Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Cannabidiol shows promise as an effective treatment for acne.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

A small dose of Platycladus orientalis leaf extract improves raccoon dogs' growth and health, but higher doses can be harmful.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Autoimmune reactions may cause both alopecia areata and HAM.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

Early regulatory T cells are crucial for normal skin pigmentation.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.